
MoonLake Immunotherapeutics (MLTX) Market Capitalization Overview
Market Cap: $2.81B as of Jun 13, 2025
$2.81B
Past Month+$415.76M (17.39%)
As of Jun 13, 2025, MoonLake Immunotherapeutics (MLTX) has a market capitalization of $2.81B. Over the past 30 days, its market cap has decreased by -0.68%, while in the last 12 months, it has decreased by -17.83%.
Market capitalization represents the total value of MoonLake Immunotherapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
MoonLake Immunotherapeutics (MLTX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of MoonLake Immunotherapeutics (MLTX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of MoonLake Immunotherapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
MoonLake Immunotherapeutics (MLTX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of MoonLake Immunotherapeutics (MLTX) helps investors assess the company's size and compare it with competitors for better investment decisions.
MoonLake Immunotherapeutics (MLTX) Market Cap & Key Trends
See MoonLake Immunotherapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in MoonLake Immunotherapeutics (MLTX)
Order type
Buy in
Order amount
Est. shares
0 shares
MoonLake Immunotherapeutics (MLTX) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $2.62B | -0.68% |
May 1, 2025 | $2.64B | +14.35% |
Apr 1, 2025 | $2.31B | -8.46% |
Mar 3, 2025 | $2.52B | -8.71% |
Feb 3, 2025 | $2.76B | -18.52% |
Jan 2, 2025 | $3.38B | -3.43% |
MoonLake Immunotherapeutics (MLTX) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $2.81B | -17.83% |
2024 | $3.42B | -5.66% |
2023 | $3.62B | +784.47% |
2022 | $409.27M | +179.51% |
2021 | $146.43M | -13.02% |
2020 | $168.34M | — |
FAQs About MoonLake Immunotherapeutics (MLTX) Market Cap
As of Jun 13, 2025, the market capitalization of MoonLake Immunotherapeutics (MLTX) is $2.81B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, MoonLake Immunotherapeutics’s market capitalization has increased by 17.39%, changing from $2.40B to $2.81B as of Jun 13, 2025.
In the last 3 months, MoonLake Immunotherapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, MoonLake Immunotherapeutics’s market capitalization decreased from $3.62B in January to $3.42B in December, reflecting a -5.66% change.
In the past five years, MoonLake Immunotherapeutics (MLTX) has had a compound annual growth rate (CAGR) of 82.58% in market capitalization. This means its market cap has grown at an average rate of 82.58% per year.